Papers
6
Total Citations
632
H-Index
6
About
Lars Philipsen is a pioneering researcher whose work sits at the intersection of proteomics, immunology, and tissue biology, with a particular focus on developing and applying advanced fluorescence microscopy technologies to unravel complex disease mechanisms. His most influential contribution is the development and promotion of Multi-Epitope-Ligand Cartography (MELC), an automated multidimensional fluorescence microscopy platform that enables high-content proteomic analysis of tissue architecture in situ — a landmark 2006 paper that has garnered nearly 500 citations and fundamentally shaped how researchers visualize and interpret protein networks within biological tissues. Building on this methodological foundation, Philipsen has applied MELC to interrogate the immunological landscapes of several significant diseases, including Crohn's disease, ulcerative colitis, psoriasis, colorectal cancer, Barrett's esophagus, and esophageal adenocarcinoma. His work has consistently demonstrated that understanding protein network environments — rather than isolated biomarkers — is essential for deciphering disease pathogenesis and treatment response. Notably, his studies on efalizumab in psoriasis provided molecular-level insight into how targeted therapies reshape tissue immunity. Across his body of work, Philipsen has established himself as a key figure in topo-proteomics, offering researchers powerful tools to translate complex molecular data into clinically meaningful discoveries.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6